DermTech Financial Statements (DMTK)

DermTechsmart-lab.ru %   2019 2020 2021 2022 2023   LTM ?
Report date 11.03.2020 05.03.2021 10.03.2022 02.03.2023 29.02.2024   15.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 3.36 5.89 11.8 14.5 15.3   15.7
Operating Income, bln rub -17.6 -35.3 -77.4 -118.2 -103.7   -90.9
EBITDA, bln rub ? -18.0 -35.3 -76.3 -118.3 -97.9   -85.3
Net profit, bln rub ? -21.9 -34.7 -77.0 -113.7 -100.9   -89.6
OCF, bln rub ? -17.8 -28.7 -62.1 -95.3 -77.0   -72.1
CAPEX, bln rub ? 0.210 1.83 2.72 3.31 0.902   0.471
FCF, bln rub ? -18.0 -30.5 -64.8 -98.6 -77.9   -72.2
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 17.7 35.2 78.7 118.8 104.0   92.2
Cost of production, bln rub 3.30 5.98 10.6 13.9 15.0   14.3
R&D, bln rub 2.50 5.29 16.3 24.1 15.2   14.1
Interest expenses, bln rub 2.66 0.040 0.000 1.34 0.000   0.775
Assets, bln rub 18.2 69.8 248.3 202.1 121.9   103.0
Net Assets, bln rub ? 12.5 63.5 229.7 132.4 57.2   40.0
Debt, bln rub 0.000 0.335 7.86 55.8 54.4   53.7
Cash, bln rub 15.4 63.8 225.3 126.2 55.9   39.0
Net debt, bln rub -15.4 -63.4 -217.5 -70.3 -1.47   14.7
Ordinary share price, rub 12.4 32.4 15.8 1.77 1.75   1.55
Number of ordinary shares, mln 7.01 17.0 28.9 30.0 32.6   34.7
Market cap, bln rub 87 551 456 53 57   54
EV, bln rub ? 71 487 239 -17 56   68
Book value, bln rub 12 63 230 132 57   40
EPS, rub ? -3.13 -2.05 -2.66 -3.79 -3.09   -2.58
FCF/share, rub -2.57 -1.80 -2.24 -3.28 -2.39   -2.08
BV/share, rub 1.78 3.74 7.95 4.41 1.75   1.15
EBITDA margin, % ? -533.9% -599.6% -644.6% -814.9% -640.0%   -544.8%
Net margin, % ? -651.1% -590.0% -650.2% -783.3% -659.6%   -572.2%
FCF yield, % ? -20.7% -5.54% -14.2% -185.4% -136.3%   -134.2%
ROE, % ? -175.4% -54.7% -33.5% -85.9% -176.5%   -224.1%
ROA, % ? -120.3% -49.8% -31.0% -56.3% -82.7%   -87.0%
P/E ? -3.97 -15.9 -5.93 -0.47 -0.57   -0.60
P/FCF -4.83 -18.0 -7.04 -0.54 -0.73   -0.74
P/S ? 25.8 93.6 38.6 3.66 3.73   3.43
P/BV ? 6.96 8.68 1.99 0.40 1.00   1.35
EV/EBITDA ? -3.98 -13.8 -3.13 0.15 -0.57   -0.80
Debt/EBITDA 0.86 1.80 2.85 0.59 0.02   -0.17
R&D/CAPEX, % 1 189% 288.6% 597.8% 727.7% 1 689%   2 993%
CAPEX/Revenue, % 6.24% 31.2% 23.0% 22.8% 5.90%   3.01%
DermTech shareholders